
The prognosis of zzso I breast cancer has generally been considered so zzso that these patients are not routinely offered zzso systemic zzso However, biological zzso within zzso dictates diverse outcomes within the zzso zzso gene amplification or protein zzso is uncommon in zzso disease, but, when present, is clearly associated with a higher risk of zzso The role of zzso therapy in these patients is zzso Few women with zzso small zzso were included in the zzso zzso zzso There are no robust data on zzso in this patient zzso although zzso analyses suggest that zzso benefits are independent of T and zzso With current guidelines and zzso committing to zzso zzso involves concurrent chemotherapy, 1 year of treatment and potential zzso A further challenge with zzso therapy is the potential benefit in patients with zzso zzso zzso within a predominantly zzso zzso The decision for therapy requires a zzso answer, but zzso status derives from a zzso of gene copy number and protein zzso The diagnostic threshold is made more complex by zzso of the zzso status within a zzso This review focuses on available data for zzso zzso disease and explores the significance of zzso zzso zzso 

